HALO - News and Analysis from Seeking Alpha 'HALO' Tag RSS Syndication from SeekingAlpha.com SeekingAlpha.com http://seekingalpha.com/symbol/halo Halozyme Therapeutics, Inc. Q3 2009 Earnings Call Transcript http://seekingalpha.com/article/171883-halozyme-therapeutics-inc-q3-2009-earnings-call-transcript?source=feed 171883 Halozyme Therapeutics, Inc. (HALO)

Q3 2009 Earnings Call Transcript

November 6, 2009 11:00 am ET

]]> Fri, 06 Nov 2009 14:59:08 -0500 Halozyme Therapeutics, Inc. (HALO)

Q3 2009 Earnings Call Transcript

November 6, 2009 11:00 am ET


Complete Story »]]> HALO Pharma M&A: Big Bonds and Small Deals http://seekingalpha.com/article/145538-pharma-m-a-big-bonds-and-small-deals?source=feed 145538 By Marie Daghlian

Though the pharmaceutical giant Merck (MRK) raised $4.25 billion in a four-part bond issue to help finance its impending acquisition of Schering Plough (SGP), last week was fairly quiet for raising capital in the life sciences. Medical device companies continued to attract venture capital, with four companies closing mid- to late-stage rounds of funding. The one bit of excitement came from a potential billion-dollar alliance between GlaxosmithKline (GSK) and Chroma Therapeutics.

]]> Fri, 26 Jun 2009 08:40:22 -0400 The Burrill Report The Burrill Report submits:

By Marie Daghlian

Though the pharmaceutical giant Merck (MRK) raised $4.25 billion in a four-part bond issue to help finance its impending acquisition of Schering Plough (SGP), last week was fairly quiet for raising capital in the life sciences. Medical device companies continued to attract venture capital, with four companies closing mid- to late-stage rounds of funding. The one bit of excitement came from a potential billion-dollar alliance between GlaxosmithKline (GSK) and Chroma Therapeutics.


Complete Story »]]> AFPC BMTI CNSO.OB CVM CYTX DYAX GSK HALO IMGN MRK NVS PFE RDY SGP SYT The Burrill Report Health Care Market Movers: SMMX, INSM, ADLS, HEB, ACUR and HALO http://seekingalpha.com/article/145104-health-care-market-movers-smmx-insm-adls-heb-acur-and-halo?source=feed 145104 Rumors, takeovers and accusations moved stocks in the market's healthcare sector as foreign investors continue to show a healthy appetite for U.S. debt. The day's flat performance followed the worst single-day decline for stocks in two months.

Laboratory Corporation of America (NYSE: LH) said on Tuesday that it has agreed to buy Monogram Biosciences Inc (Nasdaq: MGRM) a maker of diagnostic products for HIV and cancer, for about $106.7 million. That news sent MGRM shares up +2.84 (169.05%) to $4.52. Monogram said its board unanimously determined the offer to be in the best interest of the company and recommended that its stockholders tender their shares in the offer when it is made.

]]> Wed, 24 Jun 2009 09:49:39 -0400 M. E. Garza Rumors, takeovers and accusations moved stocks in the market's healthcare sector as foreign investors continue to show a healthy appetite for U.S. debt. The day's flat performance followed the worst single-day decline for stocks in two months.

Laboratory Corporation of America (NYSE: LH) said on Tuesday that it has agreed to buy Monogram Biosciences Inc (Nasdaq: MGRM) a maker of diagnostic products for HIV and cancer, for about $106.7 million. That news sent MGRM shares up +2.84 (169.05%) to $4.52. Monogram said its board unanimously determined the offer to be in the best interest of the company and recommended that its stockholders tender their shares in the offer when it is made.


Complete Story »]]> ACUR ADLS HALO HEB INSM SMMX M. E. Garza ADA Meeting 2009: Novel Diabetes Therapies Presented http://seekingalpha.com/article/144997-ada-meeting-2009-novel-diabetes-therapies-presented?source=feed 144997 By Jeffrey Martini, PhD., Vice President of MD Becker Partners LLC

Approximately 250 million people worldwide have been diagnosed with diabetes mellitus and that number is growing with the increasing obesity population. Broadly, patients with diabetes are characterized by elevated blood glucose levels that result from either insufficient insulin secretion (type-1 diabetes) or ineffective insulin action (type-2 diabetes). The market for treating patients with diabetes is large and complex and is valued at over $90 billion (Ref 1).

]]> Wed, 24 Jun 2009 03:36:07 -0400 Michael Becker Michael Becker submits:

By Jeffrey Martini, PhD., Vice President of MD Becker Partners LLC

Approximately 250 million people worldwide have been diagnosed with diabetes mellitus and that number is growing with the increasing obesity population. Broadly, patients with diabetes are characterized by elevated blood glucose levels that result from either insufficient insulin secretion (type-1 diabetes) or ineffective insulin action (type-2 diabetes). The market for treating patients with diabetes is large and complex and is valued at over $90 billion (Ref 1).


Complete Story »]]> AMLN ARNA HALO ISIS LLY NVO PFE SGMO SNY VVUS XOMA Michael Becker Halozyme Therapeutics, Inc. Q4 2008 Earnings Call Transcript http://seekingalpha.com/article/125929-halozyme-therapeutics-inc-q4-2008-earnings-call-transcript?source=feed 125929 Halozyme Therapeutics, Inc. (HALO)

Q4 2008 Earnings Call Transcript

March 13, 2009 11:00 am ET

]]> Fri, 13 Mar 2009 14:47:11 -0400 Halozyme Therapeutics, Inc. (HALO)

Q4 2008 Earnings Call Transcript

March 13, 2009 11:00 am ET


Complete Story »]]> HALO Hedge Fund Tracking: Pequot Capital Management (Art Samberg), Q3 2008 http://seekingalpha.com/article/112629-hedge-fund-tracking-pequot-capital-management-art-samberg-q3-2008?source=feed 112629 This is the Third Quarter 2008 edition of our ongoing hedge fund tracking series. Before reading this update, make sure you check out the preface to the series we're doing on Hedge Fund 13F's here.

The other funds we've already covered include:

]]> Tue, 30 Dec 2008 09:29:10 -0500 Market Folly Market Folly submits:

This is the Third Quarter 2008 edition of our ongoing hedge fund tracking series. Before reading this update, make sure you check out the preface to the series we're doing on Hedge Fund 13F's here.

The other funds we've already covered include:


Complete Story »]]> AAPL ABX AKAM AKRX ALXN AMGN APOL BAC BIDU BK BKC BNI BRCM CECO CHK CI CME CMG CREE CSX EDU EEM ELN ENER FADV FCX FMCN FSLR GLD GOOG HAL HALO HK HP ICE ISRG IWM JACK JCP JNPR JPM LPS MAPP MCO MHK MHP MSFT MT NDAQ NFLX NYX ONXX OXY PBR PODD QCOM QQQQ RIMM SGP SNDK SPR SPY STJ STT SWN UNP UPL VALE WFC WFT WMT XOM XTO Market Folly Halozyme Therapeutics, Inc. Q3 2008 Earnings Call Transcript http://seekingalpha.com/article/106797-halozyme-therapeutics-inc-q3-2008-earnings-call-transcript?source=feed 106797 Halozyme Therapeutics, Inc. (HALO)

Q3 2008 Earnings Call Transcript

November 6, 2008, 4:30 am ET

]]> Wed, 19 Nov 2008 08:24:24 -0500 Halozyme Therapeutics, Inc. (HALO)

Q3 2008 Earnings Call Transcript

November 6, 2008, 4:30 am ET


Complete Story »]]> HALO Halozyme Therapeutics Inc. Q2 2008 Earnings Call Transcript http://seekingalpha.com/article/90080-halozyme-therapeutics-inc-q2-2008-earnings-call-transcript?source=feed 90080 Halozyme Therapeutics Inc. (HALO)

Q2 2008 Earnings Call

August 8, 2008 1100 am ET

]]> Fri, 08 Aug 2008 16:54:15 -0400 Halozyme Therapeutics Inc. (HALO)

Q2 2008 Earnings Call

August 8, 2008 1100 am ET


Complete Story »]]> HALO Halozyme Therapeutics Inc. Q1 2008 Earnings Call Transcript http://seekingalpha.com/article/76655-halozyme-therapeutics-inc-q1-2008-earnings-call-transcript?source=feed 76655 Halozyme Therapeutics Inc. (HALO)

Q1 2008 Earnings Call

May 9, 2008 11:00 am ET

]]> Fri, 09 May 2008 20:02:08 -0400 Halozyme Therapeutics Inc. (HALO)

Q1 2008 Earnings Call

May 9, 2008 11:00 am ET


Complete Story »]]> HALO Halozyme Therapeutics Q4 2007 Earnings Call Transcript http://seekingalpha.com/article/68609-halozyme-therapeutics-q4-2007-earnings-call-transcript?source=feed 68609 Halozyme Therapeutics Inc. (HALO)

Q4 2007 Earnings Call

March 14, 2008 11:00 am ET

]]> Fri, 14 Mar 2008 16:54:08 -0400 Halozyme Therapeutics Inc. (HALO)

Q4 2007 Earnings Call

March 14, 2008 11:00 am ET


Complete Story »]]> HALO Critical Therapeutics Awaits FDA Decision on New Zyflo Formulation http://seekingalpha.com/article/35424-critical-therapeutics-awaits-fda-decision-on-new-zyflo-formulation?source=feed 35424 Andrew Vaino submits: Nothing really beats finding a tiny company with great potential that not too many people seem interested in. Halozyme (HALO) was trading at $2.48 last August and is now over $10. Biosante (BPA) is another excellent example, and is up over 100% since I mentioned it in February.

A perceptive reader emailed me about Critical Therapeutics (CRTX). It is a small company that sells Zyflo, a pill that inhibits 5-lipoxygenase inhibitor (5-LO). 5-lipooxygenase is responsible for the conversion of arachidonic acid to leukotrienes, which can cause constriction in the lungs. Other potential applications of a 5-LO inhibitor include vascular disease, stroke, and even pancreatic cancer. Zyflo is sold as a treatment for asthma. Seventeen million Americans have asthma, and this number is increasing.
CRTX logo

]]> Tue, 15 May 2007 04:02:04 -0400 Andrew Vaino Andrew Vaino submits:

Andrew Vaino submits: Nothing really beats finding a tiny company with great potential that not too many people seem interested in. Halozyme (HALO) was trading at $2.48 last August and is now over $10. Biosante (BPA) is another excellent example, and is up over 100% since I mentioned it in February.

A perceptive reader emailed me about Critical Therapeutics (CRTX). It is a small company that sells Zyflo, a pill that inhibits 5-lipoxygenase inhibitor (5-LO). 5-lipooxygenase is responsible for the conversion of arachidonic acid to leukotrienes, which can cause constriction in the lungs. Other potential applications of a 5-LO inhibitor include vascular disease, stroke, and even pancreatic cancer. Zyflo is sold as a treatment for asthma. Seventeen million Americans have asthma, and this number is increasing.
CRTX logo


Complete Story »]]> BPA CRTX HALO Andrew Vaino